AQR Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Buy |
|
|||||
|
2025
Q1 | $646K | Buy |
|
|||||
|
2024
Q4 | $417K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $282K | Sell |
|
|||||
|
2022
Q2 | $428K | Sell |
|
|||||
|
2022
Q1 | $1.89M | Sell |
|
|||||
|
2021
Q4 | $4.81M | Sell |
|
|||||
|
2021
Q3 | $6.37M | Buy |
|
|||||
|
2021
Q2 | $5.76M | Buy |
|
|||||
|
2021
Q1 | $2.54M | Buy |
|
|||||
|
2020
Q4 | $1.1M | Sell |
|
|||||
|
2020
Q3 | $512K | Buy |
|
|||||
|
2020
Q2 | $432K | Sell |
|
|||||
|
2020
Q1 | $538K | Sell |
|
|||||
|
2019
Q4 | $875K | Buy |
|
|||||
|
2019
Q3 | $488K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $301K | Buy |
|
|||||
|
2018
Q2 | $259K | Sell |
|
|||||
|
2018
Q1 | $312K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $563K | Buy |
|
|||||
|
2017
Q2 | $200K | Buy |
|